Skip to content

Effects of X Box Kinect 360 in Alzheimer's Disease

Effect of 3D Kinect Games With Google Cardboard on Motor Control, Cognition, and Quality of Life in Mild to Moderate Alzheimer's Patient

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07673263
Acronym
AD Alzheimer'
Enrollment
38
Registered
2026-06-29
Start date
2026-06-24
Completion date
2026-08-15
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer s Disease

Keywords

Alzheimer Disease, Virtual Reality, Kinect xbox 360

Brief summary

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia that accounting for 60% to 80% of all cases (Better, et al., 2023). According to world health organization (WHO), more than 55 million people globally live with dementia, and this number is expected to rise to 78 million by 2023 and 139 million by 2050 (WHO, 2021).

Detailed description

In the line with global epidemiology trend, the prevalence of AD is also rising at the regional level. In the United States, approximately 6.2 million individual aged 65 and older recently living with AD, and this figured is expected to reach 13.8 million by 2060 (Doher et al., 2023). Similarly, in Europe, the prevalence of AD is estimated at 5.05%, with a notably higher incidence in women (7.13%) as compared to men (3.31%) (Niu et al., 2017). Moreover, Asia alone has a higher prevalence of dementia patients than both America and Europe. A study conducted in tertiary care centers in Karachi showed that 63% of dementia patients had AD (Siddiqui et al., 2018).

Interventions

OTHER3D Kinect based game

Experimental group will receive X boc kinect 360 bomb such as match makers, traffic control, mouse mayhem, strike a pose, pizza catch, flag frenzy, follow the arrow for 30 minutes for five days a week, for six weeks.

OTHERConventional therapy group

The intervention will run for 30 minutes (excluding rest period), five days a week, for six weeks (Deng, et al., 2025). The patients will take 1-2 minutes rest after 5 minutes of activity. Rest periods of 1-2 minutes after every 5 minutes of activity.

Sponsors

Ziauddin University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

All participants will be blinded regarding treatment. A total of 38 patients will be recruited and assigned into two groups. Group A will receive Kinect Xbox game therapy exercises and Group B will receive Conventional Circuit Exercises

Intervention model description

Experimental Group Kinect game-based Rehabilitation: Device Kinect XBOX 360. Kinect game will be given 30 sessions, and intervention will run for 30 minutes (excluding rest period), five days a week, for six weeks, The patients will take 1-2 minutes rest after 5 minutes of activity. Placebo Comparator: Control Group: Conventional Rehabilitation: Conventional exercises will be given 30 sessions, and intervention will run for 30 minutes (excluding rest period), five days a week, for six weeks, The patients will take 1-2 minutes rest after 5 minutes of activity.

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Alzheimer's disease of age between 50-85 years. * Diagnosed AD stage Mild to Moderate.

Exclusion criteria

* Undiagnosed AD patients. * Mental or neurological conditions like schizophrenia, Parkinson's, or stroke.

Design outcomes

Primary

MeasureTime frameDescription
CognitionBaselineCognitive function will be assessed through among mild to moderate AD patients where low values indicate decrease in cognitive ability.
Motor FunctionBaselineMotor function will be assessed using the Timed Up and Go (TUG) Test among patients with mild to moderate Alzheimer's disease (AD), where higher scores (longer completion times) indicate poorer functional mobility
Quality of Life (QOL)BaselineQuality of life will be assessed using the Quality of Life in Alzheimer's Disease (QOL-AD) scale among patients with mild to moderate Alzheimer's disease. Lower scores indicate poorer quality of life, whereas higher scores indicate better perceived quality of life.
Quality Of Life (QOL)After 6 weeks of InterventionQuality of life will be assessed using the Quality of Life in Alzheimer's Disease (QOL-AD) scale among patients with mild to moderate Alzheimer's disease. Lower scores indicate poorer quality of life, whereas higher scores indicate better perceived quality of life.

Countries

Pakistan

Contacts

CONTACTSilvia Peter William, Mphil
williamsilviapeter@gmail.com021-36629251
PRINCIPAL_INVESTIGATORSilvia Peter William, MPhil

Ziauddin University, Karachi, Sindh, Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026